CD8A and diabetes mellitus: When assessing the influence of comorbidities on the immune response after two doses of anti-SARS-CoV-2 mRNA vaccine in dialysis patients, the results showed no significant relation between diabetes, malignancy and antibody production, levels of CD4+, CD8+ cells.